Rafael Carmena - Concepedia

Author

Rafael Carmena

Hospital Clínico Universitario de Valencia

Also Known As

D John Betteridge, H Soler Mantilla, P. Brambilla, R CARMENA, R Carmena, R. CARMENA, R. Carmena, RAFAEL CARMENA, Rafael Carmena, Y. C. Kudva

279

Publications

8.7K

Citations

H-Index

100

Concepts

All Affiliations

Hospital Clínico Universitario de Valencia Universitat de València Centro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas Hospital Arnau de Vilanova Hospital Del Mar

About

Rafael Carmena is an author at Hospital Clínico Universitario de Valencia specializing in medicine, metabolic syndrome, and atherosclerosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	48	2.5K
2	Public Health	19	26	1.5K
3	Health Sciences	15	17	453
4	Social Sciences	3	3	316
5	Natural Sciences	1	1	36

Rafael Carmena

Publications

6.5K

Citations

H-Index

Page 1

	Year	Citations
Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Di@bet.es Study Federico Soriguer, Albert Goday, Anna Bosch-Comas, Diabetologia	2011	1.1K
Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes James Shepherd, Philip J. Barter, Rafael Carmena, Diabetes Care	2006	527
Diagnosing Insulin Resistance by Simple Quantitative Methods in Subjects With Normal Glucose Metabolism Juan F. Ascaso, Susana Pardo, José T. Real, Diabetes Care	2003	486
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty‐person/ten‐country panel Philip J. Barter, Christie M. Ballantyne, Rafael Carmena, Journal of Internal Medicine	2006	470
Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study Prakash Deedwania, Philip J. Barter, Rafael Carmena, The Lancet Metabolic SyndromeNew Targets StudyCardiovascular DiseaseDiabetesLow-density Lipoprotein Cholesterol	2006	390
An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia-Full report Scott M. Grundy, Hidenori Arai, Philip J. Barter, Journal of clinical lipidology Metabolic SyndromeLipid DisorderCardiovascular EpidemiologyCardiovascular DiseaseDyslipidemia-full Report	2013	323
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS Study Julio Bobes, Celso Arango, P. Aranda, Schizophrenia Research PsychiatryPsychotic DisorderPsychotropic MedicationPsychopharmacologySchizophrenia	2006	196
Coronary Heart Disease: Reducing The Risk Gerd Assmann, Rafael Carmena, Paul Cullen, Circulation	1999	122
The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism Rafael Carmena, Ghislaine O. Roederer, H. Mailloux, Metabolism Apolipoprotein E PolymorphismMetabolic SyndromeLipid DisorderHeterozygous Familial HypercholesterolemiaCardiovascular Disease	1993	116
Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis Guntram Schernthaner, Anthony Barnett, D. J. Betteridge, Diabetologia	2010	96

Page 1